Michael E. Dee - 27 May 2021 Form 4 Insider Report for PureCycle Technologies, Inc. (PCT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
01 Jun 2021, 18:07:59 UTC
Prior SEC filing
14 May 2021
Next SEC filing
14 Jun 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brad S. Kalter, as Attorney-in-Fact

Key filing fact

Michael E. Dee filed Form 4 for PureCycle Technologies, Inc. (PCT) on 01 Jun 2021.

Key facts

  • This page summarizes Michael E. Dee's Form 4 filing for PureCycle Technologies, Inc. (PCT).
  • 4 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 01 Jun 2021, 18:07.

Change

  • Previous filing in this sequence was filed on 14 May 2021.
  • Current net transaction value: +$193,646.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PCT transaction

Common Stock

Purchase

Transaction value
$50,000
Shares
+2,936
Change %
Price
$17.03
Shares after
2,936
Date
27 May 2021
Ownership
Direct
PCT transaction

Common Stock

Purchase

Transaction value
$80,046
Shares
+4,635
Change %
+158%
Price
$17.27
Shares after
7,571
Date
28 May 2021
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PCT transaction Derivative

Common Stock Purchase Warrants

Purchase

Transaction value
$45,631
Shares
+6,303
Change %
Price
$7.24
Shares after
6,303
Date
27 May 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,303
Exercise price
$11.50
Footnotes
F2
PCT transaction Derivative

Common Stock Purchase Warrants

Purchase

Transaction value
$17,968
Shares
+2,475
Change %
+39%
Price
$7.26
Shares after
8,778
Date
28 May 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,475
Exercise price
$11.50
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.09 to $17.45 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Footnote F2

The reported price in Column 4 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $7.20 to $7.51 per warrant. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants purchased at each separate price within the range set forth in this footnote.

Footnote F3

The reported price in Column 4 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $7.20 to $7.39 per warrant. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of warrants purchased at each separate price within the range set forth in this footnote.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .